Suven Life Sciences

quarterly
yearly
ParticularsJun '21Sep '21Dec '21Mar '22Jun '22
Revenue2.011.184.434.223.54
Expenses45.6229.8438.1325.0420.20
EBITDA-43.61-28.66-33.70-20.82-16.66
EBIT-44.64-29.69-34.92-21.92-18.24
Profit Before Tax-39.21-28.30-33.69-20.80-16.33
Net Profit-39.21-28.30-33.69-20.80-16.33
Financial Ratios
Operating Profit Margin-2,170%-2,428%-760.72%-493.36%-470.62%
Net Profit Margin-1,951%-2,398%-760.50%-492.89%-461.30%
Earning Per Share (Diluted)-3.08-2.22-2.65-1.62-1.53
Dividends Per ShareNANANANANA
ⓒ 2016-2022 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 3.3.9
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  ICICI PRUDENTIAL |  HDFC |  NIPPON INDIA |  ADITYA BIRLA SUN LIFE |  SBI |  UTI |  FRANKLIN TEMPLETON |  KOTAK MAHINDRA |  IDFC |  DSP |  AXIS |  TATA |  L&T |  SUNDARAM |  PGIM |  INVESCO |  LIC |  JM FINANCIAL |  BARODA PIONEER |  CANARA ROBECO |  HSBC |  IDBI |  INDIABULLS |  MOTILAL OSWAL |  BNP PARIBAS |  MIRAE ASSET |  PRINCIPAL |  BOI AXA |  UNION KBC |  TAURUS |  EDELWEISS |  NAVI |  MAHINDRA |  QUANTUM |  PPFAS |  IIFL |  Quant |  SHRIRAM |  SAHARA |  ITI